Bacterial compound (inhibitors, antagonists)-ProbeChem.com

Request The Product List ofBacterial Bacterial

Bacteria constitute a large domain of prokaryoticmicroorganisms. Antibiotics (also called antibacterials) are a type of antimicrobial drug used in the treatment and prevention of bacterial infections, a limited number of antibiotics also possess antiprotozoal activity. Together with vaccination, antibiotics have led to the near eradication of diseases such as tuberculosis in the developed world. However, their effectiveness and easy access have also led to their overuse, prompting bacteria to develop resistance.

A bactericidal activity of antibacterials may depend on the bacterial growth phase, and it often requires ongoing metabolic activity and division of bacterial cells. In vitro characterization of antibacterial activity commonly includes the determination of the minimum inhibitory concentration and minimum bactericidal concentration of an antibacterial. To predict clinical outcome, the antimicrobial activity of an antibacterial is usually combined with its pharmacokinetic profile, and several pharmacological parameters are used as markers of drug efficacy.

Cat. No.	Product Name	Information
PC-23456	Bedaquiline Mycobacterial ATP synthase inhibitor	Bedaquiline fumarate (TMC207, R207910) is a diarylquinoline antibiotic that targets ATP synthase, inhibits Mycobacterium tuberculosis (Mtb) F1FO-ATP synthase through targeting of both the c- and the ε-subunit.
PC-23455	SQ31f Mycobacterial ATP synthase inhibitor	SQ31f is a potent non-tuberculous mycobacteria antibiotic by specifically targeting the mycobacterial F-ATP synthase, inhibits ATP hydrolysis with IC50 of 0.6 uM.
PC-23291	BTI (BrpT Inhibitor) BrpT Inhibitor	BTI (BrpT Inhibitor) is a specific small molecule inhibitor of V. vulnificus transcriptional regulator BrpT with EC50 of 6.48 uM, without affecting bacterial growth or host cell viability.
PC-23266	CBR-5992 Mtb NDH-2 inhibitor	CBR-5992 is a small molecule of Mtb type II NADH dehydrogenase (NDH-2)) inhibitor with ATP IC50 of 2.2 ug/mL, shows MIC90 of 0.5 ug/ mL against Mtb H37Rv.
PC-23224	Iclaprim DHFR inhibitor	Iclaprim (AR-100) is a selective dihydrofolate reductase (DHFR) inhibitor, is active against methicillin, TMP and vancomycin resistant strains, has MIC90 of 0.5 ug/mL against C. trachomatis and C. pneumoniae.
PC-23214	IITR07865 MreB inhibitor	IITR07865 is a small molecule bactericidal compound that targets the MreB protein of the rod complex, induces oxidative stress in E. coli cells, exhibits growth inhibitory activity against a broad spectrum of Gram-negative rod-shaped bacteria, with MIC of 4-16 μg/mL for E. coli strains.
PC-23207	GSK138 InhA inhibitor	GSK138 (GSK3081138A) is a potent, direct inhibitor of M. tuberculosis InhA with IC50 of 0.04 uM, and MIC of 1 uM against M. tuberculosis H37Rv.
PC-23201	LPC-011 LpxC inhibitor	LPC-011 is a small-molecule LpxC inhibitor with Ki of 39 nM.
PC-23181	BFstatin BrpR inhibitor	BFstatin (175C05) is a small molecule inhibitor of V. vulnificus BrpR with EC50 of 8.01 uM, a transcriptional regulator for biofilm genes.
PC-23145	SPR741 Antibiotic adjuvant	SPR741 (NAB741) is a cationic peptide derived from polymyxin B and antibiotic adjuvant, increases the permeability of the outer membrane of Gram-negative bacteria.
PC-23144	SPR741 acetate Antibiotic adjuvant	SPR741 acetate (NAB741 acetate) is a cationic peptide derived from polymyxin B and antibiotic adjuvant, increases the permeability of the outer membrane of Gram-negative bacteria.
PC-23142	Globomycin LspA inhibitor	Globomycin is a cyclic depsipeptide antibiotic, specific inhibitor of the prolipoprotein signal peptidase, inhibits the essential type II signal peptidase prolipoprotein signal peptidase (LspA), shows antimicrobial effect against Gram-negative bacteria.

PREV 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 272829 30 31 32 33 34 35 NEXT

Request The Product List ofBacterial Bacterial

Request The Product List

* Indicates a Required FieldYour information is safe with us.